US FDA Action On Regenerative Medicine May Be Hindered If Court Sides With Stem Cell Clinics

 
• By Brenda Sandburg

Pew Charitable Trusts calls for FDA to take more aggressive enforcement against regenerative medicine products, but the outcome of a bench trial involving two stem cell clinics may limit what the agency can do.

Stem cells
Greater FDA enforcement action sought against stem stell clinics • Source: Alamy

More from Cell & Gene Therapies

More from Advanced Technologies